JP Morgan Chase’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186M Sell
403,395
-97,592
-19% -$41M 0.01% 781
2026
Q1
$187M Sell
500,987
-20,913
-4% -$8.96M 0.01% 721
2025
Q4
$223M Buy
521,900
+21,932
+4% +$9.55M 0.01% 629
2025
Q3
$224M Buy
499,968
+275,423
+123% +$125M 0.01% 657
2025
Q2
$109M Sell
224,545
-21,570
-9% -$12.3M 0.01% 900
2025
Q1
$151M Sell
246,115
-20,671
-8% -$11.7M 0.01% 764
2024
Q4
$141M Buy
266,786
+20,310
+8% +$11.4M 0.01% 792
2024
Q3
$148M Sell
246,476
-24,863
-9% -$14.1M 0.01% 800
2024
Q2
$147M Buy
271,339
+21,724
+9% +$12.4M 0.01% 765
2024
Q1
$160M Sell
249,615
-6,219
-2% -$3.78M 0.01% 727
2023
Q4
$150M Sell
255,834
-31,552
-11% -$17.7M 0.01% 715
2023
Q3
$149M Buy
287,386
+24,161
+9% +$12.6M 0.02% 644
2023
Q2
$143M Buy
263,225
+15,850
+6% +$8.66M 0.02% 679
2023
Q1
$133M Buy
247,375
+2,260
+0.9% +$1.15M 0.02% 690
2022
Q4
$125M Sell
245,115
-20,519
-8% -$9.99M 0.02% 687
2022
Q3
$116M Sell
265,634
-19,849
-7% -$9.55M 0.02% 665
2022
Q2
$134M Sell
285,483
-25,572
-8% -$12.5M 0.02% 638
2022
Q1
$158M Sell
311,055
-3,858
-1% -$1.85M 0.02% 643
2021
Q4
$167M Buy
314,913
+5,247
+2% +$2.52M 0.02% 647
2021
Q3
$144M Sell
309,666
-3,834
-1% -$1.81M 0.02% 693
2021
Q2
$149M Sell
313,500
-10,260
-3% -$4.93M 0.02% 715
2021
Q1
$149M Buy
323,760
+71,077
+28% +$34.8M 0.02% 679
2020
Q4
$135M Buy
252,683
+64,820
+35% +$31.8M 0.02% 668
2020
Q3
$89.7M Sell
187,863
-549
-0.3% -$269K 0.02% 732
2020
Q2
$85M Buy
188,412
+131,405
+231% +$58.7M 0.02% 707
2020
Q1
$24.7M Buy
57,007
+17,882
+46% +$7.99M 0.01% 1128
2019
Q4
$17.2M Sell
39,125
-4,778
-11% -$2.01M ﹤0.01% 1709
2019
Q3
$18.3M Sell
43,903
-23,628
-35% -$9.64M ﹤0.01% 1648
2019
Q2
$23.8M Buy
67,531
+9,785
+17% +$3.27M ﹤0.01% 1445
2019
Q1
$18.5M Buy
57,746
+15,945
+38% +$4.9M ﹤0.01% 1596
2018
Q4
$11.8M Sell
41,801
-13,395
-24% -$4.04M ﹤0.01% 1871
2018
Q3
$17.6M Sell
55,196
-120,167
-69% -$38.3M ﹤0.01% 1761
2018
Q2
$56.4M Sell
175,363
-29,937
-15% -$9.37M 0.01% 901
2018
Q1
$56M Buy
205,300
+130,719
+175% +$34.6M 0.01% 877
2017
Q4
$18.1M Sell
74,581
-107,970
-59% -$24.5M ﹤0.01% 1650
2017
Q3
$36.1M Buy
182,551
+96,237
+111% +$18.9M 0.01% 1110
2017
Q2
$17.7M Buy
86,314
+27,027
+46% +$5.38M ﹤0.01% 1546
2017
Q1
$10.8M Sell
59,287
-18,205
-23% -$3.17M ﹤0.01% 1878
2016
Q4
$12.4M Buy
77,492
+33,060
+74% +$4.86M ﹤0.01% 1786
2016
Q3
$6.27M Sell
44,432
-81,417
-65% -$11.3M ﹤0.01% 2091
2016
Q2
$17.2M Sell
125,849
-3,428
-3% -$455K ﹤0.01% 1495
2016
Q1
$17.5M Sell
129,277
-5,286
-4% -$714K ﹤0.01% 1417
2015
Q4
$20.2M Buy
134,563
+4,123
+3% +$609K 0.01% 1321
2015
Q3
$17.4M Buy
130,440
+32,861
+34% +$4.6M ﹤0.01% 1360
2015
Q2
$12.8M Buy
97,579
+32,359
+50% +$4M ﹤0.01% 1739
2015
Q1
$7.79M Buy
65,220
+36,148
+124% +$4.01M ﹤0.01% 2060
2014
Q4
$3.07M Buy
29,072
+26,066
+867% +$2.75M ﹤0.01% 2713
2014
Q3
$309K Buy
+3,006
New +$305K ﹤0.01% 3839
2014
Q2
Sell
-470,791
Closed -$42.1M 3514
2014
Q1
$42.1M Sell
470,791
-12,554
-3% -$1.02M 0.01% 895
2013
Q4
$37M Buy
483,345
+119,865
+33% +$8.84M 0.01% 967
2013
Q3
$26M Sell
363,480
-48,102
-12% -$3.42M 0.01% 1153
2013
Q2
$29.8M Buy
+411,582
New +$30.2M 0.01% 1014

Other funds holding CHE

JP Morgan Chase's CHE Position: Q2 2026 in Review

JP Morgan Chase reduced its Chemed (CHE) stake by 19% in Q2 2026, selling an estimated $41M and leaving 403,395 shares worth $186M. The position accounts for 0.01% of the portfolio, ranked #781.

JP Morgan Chase first reported a position in CHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $224M in Q3 2025. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • JP Morgan Chase held 403,395 shares of Chemed worth $186M as of Q2 2026.
  • JP Morgan Chase sold 97,592 Chemed shares in Q2 2026, an estimated $41M.
  • Chemed made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #781 holding.
  • JP Morgan Chase first reported a position in Chemed in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Chemed position peaked at $224M in Q3 2025.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.